Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part II
by Kimberly M. Thompson, Risk Analysis 2017; 37(6):1041-1051

This short paper provides an introduction to part II of a Risk Analysis special issue on measles and rubella. Complementing Part I of the special issue, this introduction provides a contrast between other global eradication initiatives and the experience with measles and rubella eradication to date. This introduction builds on the syntheses of the literature provided in Part I and it describes the creation and application of a national risk assessment tool and the development of a dynamic disease transmission model to support global efforts to optimally manage measles and rubella globally using vaccines. Currently, efforts to eradicate measles and rubella suffer from the lack of a commitment to global eradication by key stakeholders, despite strong evidence that their eradication represents a better health and financial option than continued control.
Background on measles and rubella